Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma

European Journal of Surgical Oncology

Volumn 31, Issue 5, 2005, Pages 555-558

  Wong, T S ^a   Kwong, D L W ^a   Sham, J ^a   Wei, W I ^a   Kwong, Y L ^a   Yuen, A P W ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Head and neck cancers; Lymph node metastasis; Nasopharyngeal carcinoma; Osteopontin; Plasma

Indexed keywords

OSTEOPONTIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD ANALYSIS; CANCER PATIENT; CARCINOGENESIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; OSTEOPONTIN; SIALOGLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 19444384643     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.01.005     Document Type: Article

References (23)

1. J.P. Spano P. Busson D. Atlan et al. Nasopharyngeal carcinomas: An update Eur J Cancer 39 2003 2121-2135
2. R.J. Sanderson J.A. Ironside Squamous cell carcinomas of the head and neck BMJ 325 2002 822-827
3. M.J. Allday D.H. Crawford Role of epithelium in EBV persistence and pathogenesis of B-cell tumours Lancet 1 1988 855-857
4. D.T. Denhardt X. Guo Osteopontin: A protein with diverse functions FASEB J 7 1993 1475-1482
5. C. Gao H. Guo J. Wei P.C. Kuo Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages Biochem Biophys Res Commun 309 2003 120-125
6. M. Hirama F. Takahashi K. Takahashi et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth Cancer Lett 198 2003 107-117
7. R. Das G.H. Mahabeleshwar G.C. Kundu Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells J Biol Chem 278 2003 28593-28606
8. A.B. Tuck C. Hota S.M. Wilson A.F. Chambers Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways Oncogene 22 2003 1198-1205
9. S. Philip G.C. Kundu Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways J Biol Chem 278 2003 14487-14497
10. K. Suzuki B. Zhu S.R. Rittling et al. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts J Bone Miner Res 17 2002 1486-1497
11. G. Carlinfante D. Vassilioul O. Svensson et al. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma Clin Exp Metastasis 20 2003 437-444
12. N.S. Fedarko A. Jain A. Karadag et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer Clin Cancer Res 7 2001 4060-4066
13. A.F. Chambers S.M. Wilson N. Kerkvliet et al. Osteopontin expression in lung cancer Lung Cancer 15 1996 311-323
14. G.N. Thalmann R.A. Sikes R.E. Devoll et al. Osteopontin: Possible role in prostate cancer progression Clin Cancer Res 5 1999 2271-2277
15. D. Coppola M. Szabo D. Boulware et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin Cancer Res 10 2004 184-190
16. Q.T. Le P.D. Sutphin S. Raychaudhuri et al. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas Clin Cancer Res 9 2003 59-67
17. H.A. Gardner B. Berse D.R. Senger Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts Oncogene 9 1994 2321-2326
18. S.M. Hwang C.A. Lopez D.E. Heck et al. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells J Biol Chem 269 1994 711-715
19. J.Y. Tian E.S. Sorensen W.T. Butler et al. Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: Collagen prevents inhibition by osteopontin Cytokine 12 2000 450-457
20. T. Ibrahim I. Leong O. Sanchez-Sweatman et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases Clin Exp Metastasis 18 2000 253-260
21. Y. Saeki T. Mima T. Ishii et al. Enhanced production of osteopontin in multiple myeloma: Clinical and pathogenic Implications Br J Haematol 123 2003 263-270
22. H. Singhal D.S. Bautista K.S. Tonkin et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival Clin Cancer Res 3 1997 605-611
23. S.J. Hotte E.W. Winquist L. Stitt et al. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma Cancer 95 2002 506-512